Jump to content

Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

Search

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

Contents

(Top) 1 Chemistry 2 Brand names 3 References

Cilazapril

●العربية ●تۆرکجه ●Deutsch ●Español ●Euskara ●فارسی ●Hrvatski ●Italiano ●עברית ●Magyar ●Nederlands ●Polski ●Português ●Română ●Slovenščina ●Српски / srpski ●Srpskohrvatski / српскохрватски ●Svenska ●Українська ●Tiếng Việt Edit links ●Article ●Talk ●Read ●Edit ●View history Tools Actions ●Read ●Edit ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Cite this page ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version In other projects ●Wikimedia Commons Appearance From Wikipedia, the free encyclopedia

Cilazapril
Names

Preferred IUPAC name (1S,9S)-9-{[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid
Identifiers
CAS Number	88768-40-5^N
3D model (JSmol)	Interactive image
ChEBI	CHEBI:3698
ChEMBL	ChEMBL515606^N
ChemSpider	50831^N
DrugBank	DB01340^Y
ECHA InfoCard	100.168.764
IUPHAR/BPS	6459
KEGG	D07699^Y
PubChem CID	56330 40467985 (1R,9S)-(2S)-butylamino isomer
UNII	8Q9454114Q^N
CompTox Dashboard (EPA)	DTXSID1048629
InChI InChI=1S/C22H31N3O5/c1-2-30-22(29)18(13-12-16-8-4-3-5-9-16)23-17-10-6-14-24-15-7-11-19(21(27)28)25(24)20(17)26/h3-5,8-9,17-19,23H,2,6-7,10-15H2,1H3,(H,27,28)^N Key: HHHKFGXWKKUNCY-UHFFFAOYSA-N^N
SMILES CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(N2C1=O)C(O)=O
Properties
Chemical formula	C₂₂H₃₁N₃O₅
Molar mass	417.506 g·mol⁻¹
log P	2.212
Acidity (pK_a)	2.285
Basicity (pK_b)	11.712
Pharmacology
ATC code	C09AA08 (WHO)
Routes of administration	Oral
Legal status	UK: POM (Prescription only)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is ^YN ?) Infobox references

Cilazapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure.^[1]^[2]

It was patented in 1982 and approved for medical use in 1990.^[3]

Chemistry[edit]

Of the eight possible stereoisomers, only the all-(S)-form is medically viable.^{[citation needed]}

Brand names[edit]

It is branded as Dynorm, Inhibace, Vascace and many other names in various countries. None of these are available in the United States as of May 2010.^[4]

References[edit]

^ Szucs, T. (1991). "Cilazapril. A review". Drugs. 41 (Suppl 1): 18–24. doi:10.2165/00003495-199100411-00005. PMID 1712267. S2CID 261123720.

^ Jasek, W, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.

^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 469. ISBN 9783527607495.

^ "Cilazapril". Drugs.com. Retrieved 28 May 2010.

v t e Antihypertensive drugs acting on the renin–angiotensin system (C09)
ACE inhibitors ("-pril")	Sulfhydryl-containing: Captopril Rentiapril Zofenopril Dicarboxylate-containing: Enalapril^# Benazepril Cilazapril Delapril Imidapril Lisinopril (+amlodipine, +HCT) Moexipril Perindopril (+indapamide) Quinapril (+HCT) Ramipril Spirapril Temocapril Trandolapril Phosphonate-containing: Ceronapril Fosinopril (+HCT) Other/ungrouped: Alacepril
AIIRAs ("-sartan")	Azilsartan Candesartan Eprosartan Fimasartan Irbesartan (+HCT) Losartan (+HCT) Olmesartan (+amlodipine, +amlodipine and HCT, +HCT) Tasosartan^§ Telmisartan (+amlodipine, +HCT) Valsartan (+amlodipine, +amlodipine and HCT, +HCT, +nebivolol)
Renin inhibitors ("-kiren")	Aliskiren (+amlodipine, +HCT, +amlodipine and HCT) Remikiren^§
Dual ACE/NEP inhibitors	Gemopatrilat Ilepatril Omapatrilat Sampatrilat
Neprilysin inhibitors	Sacubitril (+valsartan)
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

t

e

Angiotensin receptor modulators

Propeptides: Angiotensinogen
Angiotensin I

Combinations:

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

t

e

Retrieved from "https://en.wikipedia.org/w/index.php?title=Cilazapril&oldid=1195315583" Categories: ●ACE inhibitors ●Carboxylic acids ●Enantiopure drugs ●Drugs developed by Hoffmann-La Roche ●Ethyl esters ●Lactams ●Prodrugs ●Nitrogen heterocycles ●Heterocyclic compounds with 2 rings ●Carboxylate esters ●Cardiovascular system drug stubs Hidden categories: ●CS1 German-language sources (de) ●Articles with short description ●Short description is different from Wikidata ●Chemical articles with multiple compound IDs ●Multiple chemicals in an infobox that need indexing ●Chemical articles with multiple PubChem CIDs ●Articles without InChI source ●Articles with changed CASNo identifier ●Articles with changed EBI identifier ●Articles with changed ChemSpider identifier ●ECHA InfoCard ID from Wikidata ●Articles with changed FDA identifier ●Articles with changed InChI identifier ●Articles containing unverified chemical infoboxes ●Chembox image size set ●Short description matches Wikidata ●All articles with unsourced statements ●Articles with unsourced statements from February 2012 ●All stub articles ●This page was last edited on 13 January 2024, at 10:06 (UTC). ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization. ●Privacy policy ●About Wikipedia ●Disclaimers ●Contact Wikipedia ●Code of Conduct ●Developers ●Statistics ●Cookie statement ●Mobile view